Skip to content
Brand AI

Kangstem Biotech

Request correction

Corporate brand

UnclaimedRead 2× by AI crawlers

A South Korean biotech company developing stem cell therapies and organoid-based technologies.

Last updated September 1, 2026

AI crawler reads

2requests

1companies
  • Anthropic2
Profile
2
Controversies
0
JSON · MD
0
First read
Nov 4, 2026
Latest read
Nov 4, 2026

From this site's server log

Overview

Kangstem Biotech is a South Korean biotech company focused on developing stem cell therapies and organoid-based technologies. The company was established on October 29, 2010, and is headquartered in Seoul. It is listed on KOSDAQ. Its main pipeline includes treatments for osteoarthritis, atopic dermatitis, and rheumatoid arthritis, as well as skin organoid technology.

History

Kangstem Biotech was established on October 29, 2010. In December 2015, it was listed on KOSDAQ. The company has developed various stem cell therapies and organoid technologies, including treatments for osteoarthritis, atopic dermatitis, and rheumatoid arthritis.

Sources3 sources

  1. 1글로벌 세포치료제 선도기업-강스템바이오텍 | mainkangstem.com
  2. 2글로벌 세포치료제 선도기업-강스템바이오텍 | 회사소개 : 연혁kangstem.com
  3. 3글로벌 세포치료제 선도기업-강스템바이오텍 | 회사소개 : About Us 강스템바이오텍kangstem.com

Cite this profile: Cite the canonical profile. /brand-wiki/kangstem-biotech-co-ltd-south-korea · Editorial policy · How profiles are compiled